Your browser doesn't support javascript.
Specific coagulation markers may provide more therapeutic targets in COVID-19 patients receiving prophylactic anticoagulant.
Tang, Ning; Bai, Huan; Xiong, Dongsheng; Sun, Ziyong.
  • Tang N; Department of Clinical Laboratory, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Bai H; Department of Clinical Laboratory, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Xiong D; Department of Clinical Laboratory, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Sun Z; Department of Clinical Laboratory, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
J Thromb Haemost ; 18(9): 2428-2430, 2020 09.
Article in English | MEDLINE | ID: covidwho-628235

Full text: Available Collection: International databases Database: MEDLINE Main subject: Fibrinolysin / COVID-19 Limits: Humans Language: English Journal: J Thromb Haemost Journal subject: Hematology Year: 2020 Document Type: Article Affiliation country: Jth.14988

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Fibrinolysin / COVID-19 Limits: Humans Language: English Journal: J Thromb Haemost Journal subject: Hematology Year: 2020 Document Type: Article Affiliation country: Jth.14988